Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-11-15 Sale(A) |
2025-02-28 6:54 pm |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
43,216 | $4.9925 | $215,754 | 167,522 (Direct) |
View |
| 2024-11-15 Sale |
2024-11-19 9:57 pm |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
43,396 | $4.9925 | $216,652 | 166,342 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-24 Option Award |
2025-02-26 5:53 pm |
N/A 2035-02-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2024-10-28 Option Award |
2024-10-30 8:32 pm |
N/A 2034-10-27 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
125,000 | $0 | 125,000 (Direct) |
View |
| 2024-02-29 Option Award(A) |
2024-03-04 06:15 am |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
100,000 | $0 | 284,738 (Direct) |
View |
| 2024-02-29 Option Award |
2024-03-01 6:42 pm |
N/A 2034-03-01 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
100,000 | $0 | 285,738 (Direct) |
View |
| 2023-11-06 Option Award |
2023-11-06 8:29 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
160,262 | $0 | 231,174 (Direct) |
View |
| 2023-08-25 Option Award |
2023-08-29 6:53 pm |
N/A 2033-08-25 |
Skye Bioscience Inc. | SKYE | ARSENAULT KAITLYN Chief Financial Officer |
16,727,648 | $0 | 17,727,648 (Direct) |
View |
| 2021-12-14 Option Award |
2021-12-16 6:59 pm |
N/A 2031-12-14 |
Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer |
2,770,000 | $0 | 2,770,000 (Direct) |
View |
| 2021-10-04 Option Award |
2021-10-05 8:42 pm |
N/A 2031-10-04 |
Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer |
1,600,000 | $0 | 2,000,000 (Direct) |
View |
Ownership |
2021-10-05 8:40 pm |
N/A 2031-09-14 |
Skye Bioscience Inc. | SKYE | Arsenault Kaitlyn Melanie Chief Financial Officer |
0 | $0 | 400,000 (Direct) |
View |